Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Point72 Asset Management L.P. | 3,007,138 5.800% | 365,885 (+13.85%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management L.P. | 163,103 5.500% | -5,609 (-3.32%) | Filing History |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | BLUE OWL CAP INC OWL | Point72 Asset Management L.P. | 0 0.000% | -1,400,000 (Position Closed) | Filing History |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Point72 Asset Management L.P. | 1,982,561 5.100% | -665,463 (-25.13%) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | ALLENA PHARMACEUTICALS COM ALNAQ | Point72 Asset Management L.P. | 0 0.000% | -4,000,000 (Position Closed) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management L.P. | 2,420,309 5.100% | -1,908,721 (-44.09%) | Filing History |
| 2022-02-14 4:34 pm Purchase | 2021-12-31 | 13G | AFFIMED N V AFMD | Point72 Asset Management L.P. | 1,185,559 9.900% | 604,098 (+103.89%) | Filing History |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | REGULUS THERAPEUTICS INC RGLS | Point72 Asset Management L.P. | 241,158 1.600% | -321,543 (-57.14%) | Filing History |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | ACORDA THERAPEUTICS INC NE ACOR | Point72 Asset Management L.P. | 23,214 4.100% | -21,954 (-48.61%) | Filing History |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Point72 Asset Management L.P. | 472,864 2.200% | 46,702 (+10.96%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | GOLAR LNG LTD GLNG | Point72 Asset Management L.P. | 4,406,367 4.100% | -1,174,969 (-21.05%) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | BAKKT HLDGS INC BKKT | Point72 Asset Management L.P. | 0 0.000% | -46,382 (Position Closed) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | FORTE BIOSCIENCES FBRX | Point72 Asset Management L.P. | 44 0.100% | -27,798 (-99.84%) | Filing History |
| 2022-02-14 4:29 pm Purchase | 2021-12-31 | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management L.P. | 2,088 5.400% | 1 (+0.05%) | Filing History |
| 2022-02-14 4:28 pm Purchase | 2021-12-31 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Point72 Asset Management L.P. | 185,366 5.200% | 2,645 (+1.45%) | Filing History |
| 2022-02-14 4:27 pm Purchase | 2021-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management L.P. | 2,657,962 5.300% | 107,226 (+4.20%) | Filing History |
| 2022-02-14 4:26 pm Purchase | 2021-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Point72 Asset Management L.P. | 1,760,248 5.000% | 8,685 (+0.50%) | Filing History |
| 2022-02-14 4:25 pm Sale | 2021-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Point72 Asset Management L.P. | 2,244 0.100% | -114,947 (-98.09%) | Filing History |
| 2022-02-11 5:05 pm Purchase | 2022-02-01 | 13G | UNIQURE N V QURE | Point72 Asset Management L.P. | 3,611,691 7.800% | 3,143,854 (+672.00%) | Filing History |
| 2022-02-10 5:07 pm Purchase | 2022-01-31 | 13G | FIBROGEN INC FGEN | Point72 Asset Management L.P. | 186,644 5.000% | 186,644 (New Position) | Filing History |